Clinical Evaluation of Biomedics Monthly Sphere and Avaira Vitality Sphere

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 3, 2024

Primary Completion Date

May 11, 2024

Study Completion Date

May 11, 2024

Conditions

Ametropia

Interventions

DEVICE

Lens A (ocufilcon D)

15 minutes of daily wear.

DEVICE

Lens B (fanfilcon A)

15 minutes of daily wear.

Trial Locations (1)

Consultorio Optométrico Queretaro, Mexico City

All Listed Sponsors

collaborator

Centre for Ocular Research & Education, Canada

OTHER

lead

CooperVision, Inc.

INDUSTRY

NCT06400914 - Clinical Evaluation of Biomedics Monthly Sphere and Avaira Vitality Sphere | Biotech Hunter | Biotech Hunter